|
SLC25A43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.958300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.208000E-02 |
| Normal-vs-Stage2 |
7.649500E-04 |
| Normal-vs-Stage3 |
6.423800E-01 |
| Normal-vs-Stage4 |
7.957200E-01 |
| Stage1-vs-Stage2 |
1.565610E-02 |
| Stage1-vs-Stage3 |
1.251830E-01 |
| Stage1-vs-Stage4 |
1.269780E-01 |
| Stage2-vs-Stage3 |
4.463900E-03 |
| Stage2-vs-Stage4 |
4.621500E-03 |
| Stage3-vs-Stage4 |
8.866200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.053400E-01 |
| Normal-vs-AfricanAmerican |
2.685700E-02 |
| Normal-vs-Asian |
7.724400E-01 |
| Caucasian-vs-AfricanAmerican |
2.364200E-01 |
| Caucasian-vs-Asian |
3.584600E-01 |
| AfricanAmerican-vs-Asian |
1.022430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.367000E-01 |
| Normal-vs-Female |
2.593500E-02 |
| Male-vs-Female |
3.405800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.340400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.376100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.029780E-01 |
| Normal-vs-Age(81-100Yrs) |
2.180400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.954400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.063800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.241000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.260600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.343770E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.583600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.169600E-02 |
| Classical-VS-Follicular |
6.57819999583253E-08 |
| Classical-VS-Other |
3.401600E-01 |
| Classical-VS-Normal |
2.993600E-01 |
| Tall-VS-Follicular |
3.73630000000125E-05 |
| Tall-VS-Other |
1.031560E-01 |
| Tall-VS-Normal |
1.577360E-01 |
| Follicular-VS-Other |
4.089000E-01 |
| Follicular-VS-Normal |
4.83530000039423E-07 |
| Other-VS-Normal |
1.527220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.621300E-04 |
| Normal-vs-N1 |
1.402950E-01 |
| N0-vs-N1 |
1.400580E-01 |
|
|
